Two separate clinical studies showed promising results in using positron emission tomography (PET) to identify patients who may be developing Alzheimer's. One PET highlights beta-amyloid plaques in the brain and the other quantifies neuronal activity in specific regions, according to MedPage Today.
The first study's images showed differences in patients who had been diagnosed with Alzheimer's and others who were suffering from different neurodegenerative conditions. Additionally, the activity study allowed researchers to discover that a tracer that signals glucose metabolism often resulted in the patient developing cognitive impairment as they got older, the media outlet reports.
There are currently no cures or preventative solutions to the development of Alzheimer's. However, researchers hope these breakthroughs can help identify patients in the early stages and possibly figure out a way to reverse or prevent the damage, possibly reducing the number of life insurance claims in the future.
While the studies focused on different areas of the disease, the results may be used together in order to develop further treatment and experimental advancements.